Kevin Coveney
Directeur Financier/CFO chez ENVERIC BIOSCIENCES, INC.
Fortune : 5 168 $ au 31/05/2024
Postes actifs de Kevin Coveney
Sociétés | Poste | Début | Fin |
---|---|---|---|
ENVERIC BIOSCIENCES, INC. | Directeur Financier/CFO | 13/03/2023 | - |
Historique de carrière de Kevin Coveney
Anciens postes connus de Kevin Coveney
Sociétés | Poste | Début | Fin |
---|---|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Directeur Financier/CFO | 01/11/2021 | 01/06/2022 |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Directeur Financier/CFO | 01/04/2020 | 01/04/2021 |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 01/11/2018 | 01/02/2020 |
Directeur Financier/CFO | 01/11/2018 | 01/02/2020 | |
Responsable des Ressources Humaines | 01/11/2018 | 01/02/2020 | |
Braver PC
Braver PC Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Braver PC provides accounting services. The company is based in Newton, MA. Braver was acquired by Marcum LLP, a SUB of Marcum Wealth LLC from The Braver Group on January 13, 2014. | Corporate Officer/Principal | 01/07/2007 | 01/10/2012 |
Formation de Kevin Coveney
University of Massachusetts | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Director of Finance/CFO | 5 |
Undergraduate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ENVERIC BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Braver PC
Braver PC Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Braver PC provides accounting services. The company is based in Newton, MA. Braver was acquired by Marcum LLP, a SUB of Marcum Wealth LLC from The Braver Group on January 13, 2014. | Commercial Services |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Vedanta Biosciences, Inc. develops microbial therapies that address the human immune system. It engages in the development of a new class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. The company was founded by Ruslan Medzhitov, Alexander Rudensky, Brett Finlay, Kenya Honda, Dan Littman, Bernat Olle and David Steinberg in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Q-State Biosciences, Inc.
Q-State Biosciences, Inc. BiotechnologyHealth Technology Q-State Biosciences, Inc. operates as Biotechnology Company. It offers cardiology, neurology, toxicity screening, drug discovery, drug efficacy screening, pathology modeling, optogenetic, electrophysiology, voltage and calcium signal. The company was founded by Adam E. Cohen, Kevin Eggan, David Margulies and Joel Kralj and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Kevin Coveney
- Expérience